NYSE · CIK 0001032220
MMS MAXIMUS, INC.
Insider trading from SEC Form 4. Last filing 11 d ago. Close $59.39 on Oct 9, 2026, +14% from the 52-week low and -39% from the high.
MAXIMUS, INC. (MMS) has 105 SEC Form 4 filings on file from 14 insiders, the latest filed on Oct 2, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $174k, net -$174k.
21 open-market trades have been scored at MMS. The newest: Michelle F. Link (Chief of Human Resources) sold $174k of stock on Oct 1, 2026, filed Oct 2, 2026, scored 11 (weak), under a 10b5-1 plan. The largest of the 21 shown: Ilene R. Baylinson (General Mgr - Health & Human) sold $988k on Feb 19, 2025, scored 60 (notable). 2 insiders bought within 14 days of each other around Feb 10, 2026.
MMS closed at $59.39 on Oct 9, 2026, 14% above its 52-week low and 39% below its 52-week high.
7 Form 144 notices of planned sales are on file, the latest filed Oct 1, 2026.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at MAXIMUS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Michelle F. Link Chief of Human Resources sell | $174k 3,208 shares | -19% | +3% from low-45% from high | |
| 2Weak | Jan Madsen director sell | $54k 742 shares | -3% | +12% from low-27% from high | |
| 45Moderate | Bruce Caswell CEO & President buy | $249k 3,175 shares | +1% | +24% from low-20% from high | |
| 42Moderate | David Mutryn Chief Financial Officer buy | $76k 1,000 shares | +3% | +18% from low-24% from high | |
| 15Weak | Michelle F. Link Chief of Human Resources sell | $351k 4,039 shares | -17% | +33% from low-7% from high | |
| 18Weak | Michael J. Warren director buy | $1,240 14 shares | +0% | +35% from low-5% from high | |
| 18Weak | Gayathri Rajan director buy | $3,643 42 shares | +0% | +35% from low-5% from high | |
| 11Weak | Michelle F. Link Chief of Human Resources sell | $146k 1,610 shares | -11% | +42% from low-1% from high | |
| 18Weak | Michael J. Warren director buy | $1,236 14 shares | +0% | +38% from low-4% from high | |
| 18Weak | Gayathri Rajan director buy | $3,630 41 shares | +0% | +38% from low-4% from high | |
| 34Weak | Raymond B Ruddy director buy | $100k 1,435 shares | +0% | +8% from low-25% from high | |
| 22Weak | Michael J. Warren director buy | $1,231 17 shares | +0% | +13% from low-21% from high | |
| 22Weak | Gayathri Rajan director buy | $5,979 83 shares | +1% | +13% from low-21% from high | |
| 44Moderate | Gayathri Rajan director sell | $573k 7,913 shares | -36% | +13% from low-21% from high | |
| 60Notable | Ilene R. Baylinson General Mgr - Health & Human sell | $988k 14,500 shares | -85% | - | |
| 53Moderate | Bruce Caswell CEO & President buy | $247k 3,500 shares | +1% | - | |
| 43Moderate | John J Haley director buy | $250k 3,490 shares | +3% | - | |
| 43Moderate | Raymond B Ruddy director buy | $249k 3,490 shares | +3% | - | |
| 36Weak | Michelle F. Link Chief of Human Resources sell | $163k 2,208 shares | -25% | - | |
| 25Weak | Michael J. Warren director buy | $1,220 17 shares | +0% | - | |
| 25Weak | Gayathri Rajan director buy | $5,395 73 shares | +0% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 1, 2026 | Link Michelle F. Officer | 3,208 0.01% of outstanding | $174k | Oct 1, 2026 | none |
| Mar 17, 2026 | Madsen Jan Director | 742 0.00% of outstanding | $54k | Mar 17, 2026 | none |
| Dec 3, 2025 | Link Michelle F. Officer | 4,039 0.01% of outstanding | $351k | Dec 3, 2025 | $146k |
| Oct 1, 2025 | Link Michelle F. Officer | 1,610 0.00% of outstanding | $146k | Oct 1, 2025 | none |
| May 30, 2025 | RAJAN GAYATHRI Director | 7,914 0.01% of outstanding | $573k | May 30, 2025 | none |
| Mar 18, 2025 | Madsen Jan Director | 2,439 0.00% of outstanding | $165k | Mar 18, 2025 | none |
| Dec 3, 2024 | Link Michelle F. Officer | 2,208 0.00% of outstanding | $163k | Dec 3, 2024 | $126k |
Transactions
The newest 50 of 137 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ilene R. Baylinson General Mgr - Health & Human | FTax withholding Common Stock | -3,945 | $53.19 | $210k | 21,689 | 11 d ago |
| Sep 30, 2026 | Theresa D Golinvaux Principal Accounting Officer | FTax withholding Common Stock | -1,244 | $53.19 | $66k | 12,349 | 11 d ago |
| Sep 30, 2026 | David Mutryn Chief Financial Officer | FTax withholding Common Stock | -4,749 | $53.19 | $253k | 35,614 | 11 d ago |
| Sep 30, 2026 | Michelle F. Link Chief of Human Resources | FTax withholding Common Stock10b5-1 | -2,637 | $53.19 | $140k | 17,089 | 11 d ago |
| Sep 30, 2026 | Elizabeth Moellering General Counsel and Corp. Sec. | FTax withholding Common Stock | -713 | $53.19 | $38k | 4,382 | 11 d ago |
| Oct 1, 2026 | Michelle F. Link Chief of Human Resources | SOpen-market sale Common Stock10b5-1 | -3,208 | $54.23 | $174k | 13,881 | 11 d ago |
| Mar 17, 2026 | Jan Madsen director | SOpen-market sale Common Stock10b5-1 | -742 | $72.25 | $54k | 20,795 | Mar 17, 2026 |
| Mar 10, 2026 | Anne K. Altman director | AGrant or award Common Stock | +3,062 | $0.00 | $0 | 35,142 | Mar 12, 2026 |
| Mar 10, 2026 | John J Haley director | AGrant or award Common Stock | +7,009 | $0.00 | $0 | 47,116 | Mar 12, 2026 |
| Mar 10, 2026 | Gayathri Rajan director | AGrant or award Common Stock | +2,246 | $0.00 | $0 | 16,705 | Mar 12, 2026 |
| Mar 10, 2026 | Michael J. Warren director | AGrant or award Common Stock | +2,246 | $0.00 | $0 | 17,839 | Mar 12, 2026 |
| Mar 10, 2026 | Jan Madsen director | AGrant or award Common Stock | +3,215 | $0.00 | $0 | 21,537 | Mar 12, 2026 |
| Feb 27, 2026 | Richard A Montoni director | GGift Common Stockindirect: In Trust | -7,000 | $0.00 | $0 | 45,500 | Mar 2, 2026 |
| Feb 24, 2026 | Richard A Montoni director | GGift Common Stockindirect: In Trust | -3,000 | $0.00 | $0 | 52,500 | Feb 25, 2026 |
| Feb 18, 2026 | John J Haley director | GGift Common Stockindirect: By John J. Haley Revocable Trust | -32,764 | $0.00 | $0 | 0 | Feb 19, 2026 |
| Feb 18, 2026 | John J Haley director | GGift Common Stockindirect: By John J. Haley Grantor Retained Annuity Trust Eight | +32,764 | $0.00 | $0 | 32,764 | Feb 19, 2026 |
| Feb 10, 2026 | John J Haley director | GGift Common Stock | -32,764 | $0.00 | $0 | 39,971 | Feb 11, 2026 |
| Feb 10, 2026 | Bruce Caswell CEO & President | POpen-market purchase Common Stock | +152 | $76.92 | $12k | 324,990 | Feb 11, 2026 |
| Feb 10, 2026 | Bruce Caswell CEO & President | POpen-market purchase Common Stock | +1,332 | $78.22 | $104k | 326,322 | Feb 11, 2026 |
| Feb 10, 2026 | John J Haley director | GGift Common Stockindirect: By John J. Haley Revocable Trust | +32,764 | $0.00 | $0 | 32,764 | Feb 11, 2026 |
| Feb 10, 2026 | Bruce Caswell CEO & President | POpen-market purchase Common Stock | +1,691 | $78.77 | $133k | 328,013 | Feb 11, 2026 |
| Feb 9, 2026 | David Mutryn Chief Financial Officer | POpen-market purchase Common Stock | +1,000 | $75.63 | $76k | 40,037 | Feb 9, 2026 |
| Dec 2, 2025 | Bruce Caswell CEO & President | AGrant or award Common Stock | +96,187 | $0.00 | $0 | 372,116 | Jan 20, 2026 |
| Dec 2, 2025 | Bruce Caswell CEO & President | FTax withholding Common Stock | -47,276 | $86.51 | $4.1M | 324,838 | Jan 20, 2026 |
| Dec 2, 2025 | David Mutryn Chief Financial Officer | AGrant or award Common Stock | +13,391 | $0.00 | $0 | 45,076 | Dec 3, 2025 |
| Dec 2, 2025 | Ilene R. Baylinson General Mgr - Health & Human | AGrant or award Common Stock | +7,647 | $0.00 | $0 | 29,224 | Dec 3, 2025 |
| Dec 2, 2025 | Bruce Caswell CEO & President | AGrant or award Common Stock | +13,391 | $0.00 | $0 | 45,076 | Dec 3, 2025 |
| Dec 2, 2025 | Theresa D Golinvaux Principal Accounting Officer | AGrant or award Common Stock | +1,201 | $0.00 | $0 | 14,029 | Dec 3, 2025 |
| Dec 2, 2025 | Michelle F. Link Chief of Human Resources | AGrant or award Common Stock10b5-1 | +7,358 | $0.00 | $0 | 26,899 | Dec 3, 2025 |
| Dec 2, 2025 | David Mutryn Chief Financial Officer | FTax withholding Common Stock | -6,040 | $86.51 | $522k | 39,037 | Dec 3, 2025 |
| Dec 2, 2025 | Ilene R. Baylinson General Mgr - Health & Human | FTax withholding Common Stock | -3,831 | $86.51 | $331k | 25,393 | Dec 3, 2025 |
| Dec 2, 2025 | Bruce Caswell CEO & President | FTax withholding Common Stock | -39,037 | $86.51 | $3.4M | 39,037 | Dec 3, 2025 |
| Dec 2, 2025 | Theresa D Golinvaux Principal Accounting Officer | FTax withholding Common Stock | -542 | $86.51 | $47k | 13,488 | Dec 3, 2025 |
| Dec 2, 2025 | Michelle F. Link Chief of Human Resources | FTax withholding Common Stock10b5-1 | -3,319 | $86.51 | $287k | 23,581 | Dec 3, 2025 |
| Dec 3, 2025 | Michelle F. Link Chief of Human Resources | SOpen-market sale Common Stock10b5-1 | -4,039 | $86.84 | $351k | 19,542 | Dec 3, 2025 |
| Dec 1, 2025 | Anne K. Altman director | AGrant or award Common Stock | +11 | $0.00 | $0 | 32,066 | Dec 2, 2025 |
| Dec 1, 2025 | Ilene R. Baylinson General Mgr - Health & Human | AGrant or award Common Stock | +28 | $0.00 | $0 | 21,577 | Dec 2, 2025 |
| Dec 1, 2025 | Theresa D Golinvaux Principal Accounting Officer | AGrant or award Common Stock | +14 | $0.00 | $0 | 12,829 | Dec 2, 2025 |
| Dec 1, 2025 | John J Haley director | AGrant or award Common Stock | +104 | $0.00 | $0 | 39,971 | Dec 2, 2025 |
| Dec 1, 2025 | Michelle F. Link Chief of Human Resources | AGrant or award Common Stock | +20 | $0.00 | $0 | 19,541 | Dec 2, 2025 |
| Dec 1, 2025 | Raymond B Ruddy director | AGrant or award Common Stock | +694 | $0.00 | $0 | 315,940 | Dec 2, 2025 |
| Dec 1, 2025 | Jan Madsen director | AGrant or award Common Stock | +50 | $0.00 | $0 | 18,257 | Dec 2, 2025 |
| Dec 1, 2025 | David Mutryn Chief Financial Officer | AGrant or award Common Stock | +37 | $0.00 | $0 | 31,685 | Dec 2, 2025 |
| Dec 1, 2025 | John Thomas Martinez Chief Legal Officer | AGrant or award Common Stock | +33 | $0.00 | $0 | 22,641 | Dec 2, 2025 |
| Dec 1, 2025 | Richard A Montoni director | GGift Common Stockindirect: In Trust | -12,000 | $0.00 | $0 | 55,500 | Dec 2, 2025 |
| Nov 28, 2025 | Michael J. Warren director | POpen-market purchase Common Stock | +14 | $86.11 | $1,240 | 15,485 | Dec 2, 2025 |
| Nov 28, 2025 | Gayathri Rajan director | POpen-market purchase Common Stock | +42 | $86.11 | $3,643 | 14,388 | Dec 2, 2025 |
| Dec 1, 2025 | Michael J. Warren director | AGrant or award Common Stock | +39 | $0.00 | $0 | 15,524 | Dec 2, 2025 |
| Dec 1, 2025 | Gayathri Rajan director | AGrant or award Common Stock | +8 | $0.00 | $0 | 14,396 | Dec 2, 2025 |
| Nov 24, 2025 | Ilene R. Baylinson General Mgr - Health & Human | AGrant or award Common Stock | +7,409 | $0.00 | $0 | 21,549 | Nov 25, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Anne K. Altmandirector
- Ilene R. BaylinsonGeneral Mgr - Health & Human
- Bruce CaswellCEO & President
- Theresa D GolinvauxPrincipal Accounting Officer
- John J Haleydirector
- Michelle F. LinkChief of Human Resources
- Richard A Montonidirector
- Jan Madsendirector
- John Thomas MartinezChief Legal Officer
- Elizabeth MoelleringGeneral Counsel and Corp. Sec.
- David MutrynChief Financial Officer
- Gayathri Rajandirector
- Raymond B Ruddydirector
- Michael J. Warrendirector
Questions about MMS
Answered from the filings on this page, as of the latest one.
Are insiders buying MMS?
As of Oct 2, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $174k by 1 insider at MAXIMUS, INC. in the last 90 days, net -$174k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade MMS on the open market?
Michelle F. Link (Chief of Human Resources) sold $174k of MMS on Oct 1, 2026 and filed the Form 4 on Oct 2, 2026. InsiderTell scored 11 (weak), under a 10b5-1 plan.
How many insiders file Form 4 at MAXIMUS, INC.?
14 people have filed a Form 4 at MAXIMUS, INC., among them Anne K. Altman (director), Ilene R. Baylinson (General Mgr - Health & Human), Bruce Caswell (CEO & President). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.